Showing results (301-310 of 439) with videos related to

Sort By:
Pageof 44
Journal of the American College of Cardiology|September 24, 2021
Empagliflozin Improves Cardiovascular and Renal Outcomes in Heart Failure Irrespective of Systolic Blood PressureMichael Böhm, Stefan D Anker, Javed Butler, et al.
Open Heart|December 16, 2021
Atrial fibrillation and clinical outcomes 1 to 3 years after myocardial infarctionAnthony P Carnicelli, Ruth Owen, Stuart J Pocock, et al.
Clinical Cardiology|December 17, 2017
Rationale and design of the long-Term rIsk, clinical manaGement, and healthcare Resource utilization of stable coronary artery dISease in post-myocardial infarction patients (TIGRIS) studyDirk Westermann, Shaun G Goodman, José C Nicolau, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 25, 2020
Drug-coated stents versus bare metal stents in Academic Research Consortium-defined high bleeding risk patientsGuillaume Marquis-Gravel, Philip Urban, Samuel Copt, et al.
Open Heart|August 21, 2023
Long-term outcomes among stable post-acute myocardial infarction patients living in rural versus urban areas: insights from the prospective, observational TIGRIS registryJose Carlos Nicolau, Ruth Owen, Remo H M Furtado, et al.
Journal of the American College of Cardiology|June 30, 2022
Empagliflozin Improves Outcomes in Patients With Heart Failure and Preserved Ejection Fraction Irrespective of AgeMichael Böhm, Javed Butler, Gerasimos Filippatos, et al.
Circulation|June 24, 2022
Socioeconomic Deprivation: An Important, Largely Unrecognized Risk Factor in Primary Prevention of Cardiovascular DiseaseDorien M Kimenai, Leah Pirondini, John Gregson, et al.
BMC Cardiovascular Disorders|July 6, 2018
Predictors of high-cost hospitalization in the treatment of acute coronary syndrome in Asia: findings from EPICOR AsiaStephen Jan, Stephen W-L Lee, Jitendra P S Sawhney, et al.
The New England Journal of Medicine|December 3, 1998
A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study InvestigatorsM B Leon, D S Baim, J J Popma, et al.
International Journal of Cardiology|March 21, 2020
Antithrombotic management and long-term outcomes following percutaneous coronary intervention for acute coronary syndrome in AsiaShuning Zhang, Wei Wang, Jitendra P S Sawhney, et al.
Pageof 44